| Jul 24 |
What's in Store for Structure Therapeutics (GPCR) in Q2 Earnings?
|
| Jul 17 |
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
|
| Jul 15 |
Peering Into Structure Therapeutics's Recent Short Interest
|
| Jul 12 |
The 3 Most Undervalued Biotech Stocks to Buy in July 2024
|
| Jun 17 |
Could Structure Therapeutics Become the Next Novo Nordisk?
|
| Jun 14 |
Structure Therapeutics: Yet Another Potential GLP-1 Entrant
|
| Jun 11 |
Structure Therapeutics (GPCR) Rallying on Obesity Drug Data
|
| Jun 11 |
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?
|
| Jun 9 |
Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?
|
| Jun 7 |
Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares
|
